Bloomberg Daybreak with Karen Moskow and Nathan Hager. GUESTS: Vladimir Tenev. CEO/Co-Founder. Robinhood Financial LLC. ran taped
See Original Article

In November, a team of independent advisors to the FDA sharply criticized the data supporting Biogen’s drug, known as aducanumab, which left investors fearful of an outright rejection. That the agency has now moved the approval deadline back to June 7 …
See Original Article

Shares of Marston's jumped as much as 30% after Bloomberg News first reported the approach. They were up 17% at 1:29 p.m. Friday in London,
See Original Article

Eli Lilly’s COVID-19 antibody stole the show during the fourth quarter, and the company says there’s more to come as the U.S. government just placed another big order—and Lilly itself projects blockbuster coronavirus revenues in 2021. Lilly’s first COVID-19 …
See Original Article

But it came under scrutiny for its accounting practices and potential financial misconduct after the Financial Times ran stories this year about suspect
See Original Article